Annual Drug Patent Expirations for RISPERDAL+CONSTA
Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
RISPERDAL CONSTA drug price trends.
Drug patent litigation for RISPERDAL CONSTA.
The generic ingredient in RISPERDAL CONSTA is risperidone. One supplier is listed for this compound. Additional details are available on the risperidone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
